sponsored links

EU agency backs new Roche, Astellas, Sanofi, Vivus drugs

Sponsored Links

LONDON (Reuters) – European regulators have recommended approval of two new cancer drugs, called Erivedge and Xtandi, from Roche and Astellas. The European Medicines Agency said on Friday its experts had also backed MAC1, a tissue-engineered medicine for cartilage defects from Sanofi, and Spedra, a new erectile dysfunction drug from Vivus. Recommendations for marketing approval by the EMA’s Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months. (Reporting by Ben Hirschler)

View full post on Health News Headlines – Yahoo! News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.